Supernus Pharmaceuticals (SUPN)

Add to Watchlists
Create an Alert
8.26 +0.07  +0.85% NASDAQ Apr 17, 8:00PM BATS Real time Currency in USD
View Full Chart
SUPN Price Chart
View All Events

SUPN Events

Date Type Description
Mar 13 Misc Q4 2013 Supernus Earnings Conference Call
Mar 13 Earnings Q4 2013 Supernus Earnings Results. Estimate: -0.54.
Nov 12 Misc Supernus Announces Third Quarter 2013 Earnings Conference Call and Webcast
Nov 12 Earnings Supernus Announces Third Quarter 2013 Earnings Results. Estimate: -0.67.
Aug 13 Misc Supernus Announces Second Quarter 2013 Earnings Conference Call and Webcast
Aug 13 Earnings Supernus Announces Second Quarter 2013 Earnings Results. Estimate: -0.68.
May 13 Misc Supernus Announces First Quarter 2013 Earnings Conference Call and Webcast
May 13 Earnings Q1 2013 Earnings Results. Estimate: -0.63.
View All Performance Charts

SUPN Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Supernus Pharmaceuticals is up 55.26% over the last year vs S&P 500 Total Return up 20.96%, Actavis up 103.6%, and Impax Laboratories up 47.44%.

Get Quote for
Advertisement

Portfolio Strategies Featuring SUPN

Did Supernus Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

SUPN Profile

  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Headquarters Country: United States
  • Headquarters State/Province: Maryland
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Supernus Pharmaceuticals Inc., is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system, or CNS, diseases.

Recent Quotes

Symbol Price Chg Chg % Market Cap
SUPN 8.26 +0.07 +0.85% 330.26M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.